Zendal Group
Press
Careers

You are on Vetia’s International website.

Go to Vetia Spain

COLIDEX-C Vacuna inactivada frente a la diarrea neonatal y posdestete, enfermedad de los edemas y enteritis necrótica en porcino

The packaging image may vary depending on the country in which it is marketed.

Logotipo CZ Vaccines
Manufacturer
CZ Vaccines, S.A.U
Medicinal product subject to veterinary prescription

COLIDEX-C

Inactivated vaccine against neonatal and post-weaning diarrhoea, oedema disease and necroticenteritis in pigs, in an injectable emulsion
REQUEST MORE INFO
Target species
Pigs icon
Pigs
Composition per dose (2 ml)
Active substance:
Inactivated E. coli (F4ac adhesin), strain P6 ≥1 PR*
Inactivated E. coli (F5 adhesin), strain P1 ≥1 PR*
Inactivated E. coli (F6 adhesin), strain P2 and P4 ≥1 PR*
Inactivated E. coli (F5 + F41 adhesin), strain P10 ≥1 PR*
Inactivated E. coli (F18ab adhesin), strain P5 ≥1 PR*
Inactivated E. coli (F18ac adhesin), strain P9 ≥1 PR*
β Toxoid of Clostridium perfringens type C ≥10 UI**

*RP: Relative potency for each antigen according to a reference vaccine that has passed the immunogenicity test (Ph. Eur. m 0962).

**IU: International Units of antitoxin according to monograph 0363 of the Ph. Eur.


Adyuvante:
Light Mineral Oil (Marcol 52) 0,76 ml
Montane 80 0,042 ml
Montanide 103 0,042 ml
Indications
Sows: Active immunisation of sows and passive immunisation of piglets to prevent colibacillosis caused by E. coli strains; against oedema disease and necrotic enteritis caused by C. perfringens type C as follows:
  • Neonatal piglets:
    • Reduces mortality and clinical signs (severe diarrhoea) due to colibacillosis.
    • Reduces mortality and clinical signs due to necrotic enteritis caused by C. perfringens type C.
  • Weaned piglets:
    • Reduces mortality and clinical signs due to oedema disease.
    • Reduces clinical signs (severe diarrhoea) of colibacillosis.
    • Reduces clinical signs of chronic enteritis caused by C. perfringens type C.
    • Duration of immunity:
    • 21 days for infections caused by F4ac, F18ac (colibacillosis) and Clostridium perfringens type C (necrotic enteritis).
    • 21 days for antibodies against F5, F6 and F41.
    • 28 days for infections caused by F18ab (oedema disease).


Piglets: Active immunisation of piglets against post-weaning diarrhoea.
Route of administration
Intramuscular.
Dosage
Sows (primiparous and multiparous): 2 ml
Piglets: First dose: 0.5 ml, Second dose: 1 ml
Vaccination schedule:
  • Primary vaccination
    • Pregnant sows 2 doses.
      • First dose 6 to 7 weeks before parturition
      • Second dose 4 weeks before parturition
    • Piglets 2 doses.
      • First dose at 10 days of age (0.5 ml)
      • Second dose at weaning (1 ml)

  • Revaccination:
    • Cerda gestante.
      • 1 dose. 4 weeks before parturition
Withdrawal period
Zero days.
COLIDEX-C Vacuna inactivada frente a la diarrea neonatal y posdestete, enfermedad de los edemas y enteritis necrótica en porcino

La imagen puede variar dependiendo del país en el que se comercialice.

Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria

COLIDEX-C

Inactivated vaccine against neonatal and post-weaning diarrhoea, oedema disease and necroticenteritis in pigs, in an injectable emulsion
SOLICITE INFORMACIÓN
PREVENTING WITH EXPERTS
Composición por dosis (2 ml)
Active substance:
Inactivated E. coli (F4ac adhesin), strain P6 ≥1 PR*
Inactivated E. coli (F5 adhesin), strain P1 ≥1 PR*
Inactivated E. coli (F6 adhesin), strain P2 and P4 ≥1 PR*
Inactivated E. coli (F5 + F41 adhesin), strain P10 ≥1 PR*
Inactivated E. coli (F18ab adhesin), strain P5 ≥1 PR*
Inactivated E. coli (F18ac adhesin), strain P9 ≥1 PR*
β Toxoid of Clostridium perfringens type C ≥10 UI**

*RP: Relative potency for each antigen according to a reference vaccine that has passed the immunogenicity test (Ph. Eur. m 0962).

**IU: International Units of antitoxin according to monograph 0363 of the Ph. Eur.


Adyuvante:
Light Mineral Oil (Marcol 52) 0,76 ml
Montane 80 0,042 ml
Montanide 103 0,042 ml
Indicaciones
Sows: Active immunisation of sows and passive immunisation of piglets to prevent colibacillosis caused by E. coli strains; against oedema disease and necrotic enteritis caused by C. perfringens type C as follows:
  • Neonatal piglets:
    • Reduces mortality and clinical signs (severe diarrhoea) due to colibacillosis.
    • Reduces mortality and clinical signs due to necrotic enteritis caused by C. perfringens type C.
  • Weaned piglets:
    • Reduces mortality and clinical signs due to oedema disease.
    • Reduces clinical signs (severe diarrhoea) of colibacillosis.
    • Reduces clinical signs of chronic enteritis caused by C. perfringens type C.
    • Duration of immunity:
    • 21 days for infections caused by F4ac, F18ac (colibacillosis) and Clostridium perfringens type C (necrotic enteritis).
    • 21 days for antibodies against F5, F6 and F41.
    • 28 days for infections caused by F18ab (oedema disease).


Piglets: Active immunisation of piglets against post-weaning diarrhoea.
Vía de administración
Intramuscular.
Posología
Sows (primiparous and multiparous): 2 ml
Piglets: First dose: 0.5 ml, Second dose: 1 ml
Pauta de vacunación
  • Primary vaccination
    • Pregnant sows 2 doses.
      • First dose 6 to 7 weeks before parturition
      • Second dose 4 weeks before parturition
    • Piglets 2 doses.
      • First dose at 10 days of age (0.5 ml)
      • Second dose at weaning (1 ml)

  • Revaccination:
    • Cerda gestante.
      • 1 dose. 4 weeks before parturition
Tiempo de espera
Zero days.
Scroll to Top